Cited by

• Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalis.

  Skinner GR, Woodman CB, Hartley CE, Buchan A, Fuller A, Durham J, Synnott M, Clay JC, Melling J, Wiblin C, Wilkins J. Skinner GR, et al. Br J Vener Dis. 1982 Dec;58(6):381-6. doi: 10.1136/sti.58.6.381. Br J Vener Dis. 1982. PMID: 6293640 Free PMC article.
• Prospects and perspectives for development of a vaccine against herpes simplex virus infections.

  McAllister SC, Schleiss MR. McAllister SC, et al. Expert Rev Vaccines. 2014 Nov;13(11):1349-60. doi: 10.1586/14760584.2014.932694. Epub 2014 Jul 31. Expert Rev Vaccines. 2014. PMID: 25077372 Free PMC article. Review.
• The preparation, efficacy and safety of 'antigenoid' vaccine NFU1 (S-L+) MRC toward prevention of herpes simplex virus infections in human subjects.

  Skinner GR, Buchan A, Hartley CE, Turner SP, Williams DR. Skinner GR, et al. Med Microbiol Immunol. 1980;169(1):39-51. doi: 10.1007/BF02123711. Med Microbiol Immunol. 1980. PMID: 6258035
• Prepubertal vaccination of mice against experimental infection of the genital tract with type 2 herpes simplex virus.

  Skinner GR, Williams DR, Moles AW, Sargent A. Skinner GR, et al. Arch Virol. 1980;64(4):329-38. doi: 10.1007/BF01320618. Arch Virol. 1980. PMID: 6249243 Free PMC article.
• Immunogenicity and protective efficacy in a rhesus monkey model of vaccine Ac NFUi(S-) MRC against primary type 2 herpes simplex virus infection.

  Skinner GR, Buchan A, Williams D, Marsden J, Hartley C, Wilbanks G, Turyk M, Namkoong ES. Skinner GR, et al. Br J Exp Pathol. 1982 Aug;63(4):378-87. Br J Exp Pathol. 1982. PMID: 6295430 Free PMC article.